Disease Site Blood/Bone Marrow You have free access to this content Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma (pages 873–878)
Ora Israel, Maya Mor, Ron Epelbaum, Alex Frenkel, Nissim Haim, Eldad J. Dann, Diana Gaitini, Rachel Bar-Shalom, Gerald M. Kolodny and Dov Front
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10344
Ga-67 scintigraphy performed early during treatment is a better predictor of response rate and 5-year failure-free survival than pretreatment risk factors in patients with aggressive non-Hodgkin lymphoma.
You have free access to this content Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma (pages 879–888)
Lale Kostakoglu, John P. Leonard, Ichiei Kuji, Morton Coleman, Shankar Vallabhajosula and Stanley J. Goldsmith
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10336
In imaging aggressive lymphoma and Hodgkin disease patients before therapy, fluorodeoxyglucose positron emission tomography (FDG-PET) has significantly higher site and patient sensitivity than Ga-67 scintigraphy (100% vs. 71.5% and 100% vs. 80.3%, respectively). The change in disease stage by FDG-PET may result in a change in therapy strategy.
Breast Disease You have free access to this content Results of the Lynn Sage Second-Opinion Program for local therapy in patients with breast carcinoma : Changes in management and determinants of where care is delivered (pages 889–894)
Jennifer Clauson, Y. C. Hsieh, Simbi Acharya, Alfred W. Rademaker and Monica Morrow
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10318
A second-opinion program for the local therapy of patients with breast carcinoma resulted in a change in management recommendations for 20.3% of 231 patients. Sixty-six percent of patients opted to be treated at the second-opinion institution.
You have free access to this content Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study (pages 895–901)
Andrea de Matteis, Francesco Nuzzo, Giuseppe D'Aiuto, Vincenzo Labonia, Gabriella Landi, Emanuela Rossi, Angelo Antonio Mastro, Gerardo Botti, Ermelinda De Maio and Francesco Perrone
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.20335
Neoadjuvant chemotherapy with epirubicin plus docetaxel was a feasible and active treatment in an unfavorable series of patients with locally advanced breast carcinoma, including patients with inflammatory breast carcinoma.
Gastrointestinal Tract You have free access to this content Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma : A prospective, randomized phase III study of the Gruppo Oncologico dell'italia Meridionale (pages 902–910)
Giuseppe Colucci, Francesco Giuliani, Vittorio Gebbia, Maria Biglietto, Piergiorgio Rabitti, Generoso Uomo, Silvio Cigolari, Antonio Testa, Evaristo Maiello and Massimo Lopez
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10323
This Phase III trial compared the activity and toxicity of gemcitabine with or without cisplatin on a weekly schedule in patients with locally advanced and/or metastatic pancreatic adenocarcinoma. The time to disease progression and the overall response rate were statistically superior in the combination arm over single-agent gemcitabine. No difference was recorded in overall survival.
You have free access to this content Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma (pages 911–920)
Taiji Furukawa, Fumio Konishi, Kazuhisa Shitoh, Masayuki Kojima, Hideo Nagai and Toshihiko Tsukamoto
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10332
The Japanese clinical criteria A and an age at onset younger than 50 years are suitable for selecting cases to analyze for gene mutations to diagnose hereditary nonpolyposis colorectal carcinoma, but the Japanese clinical criteria B are not useful for the clinical setting. Analyzing
TGFβ RII mutations and immunohistochemical staining of hMLH1 or hMSH2 for cases with microsatellite instability phenotype are useful for selecting cases that should be tested for germline mutations. You have free access to this content Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma (pages 921–928)
Hiroyuki Kato, Hiroyuki Kuwano, Masanobu Nakajima, Tatsuya Miyazaki, Minako Yoshikawa, Hitoshi Ojima, Katsuhiko Tsukada, Noboru Oriuchi, Tomio Inoue and Keigo Endo
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10330
In this study, 18-F-fluorodeoxyglucose positron emission tomography (FDG-PET) was used as a noninvasive diagnostic technique in assessing the aggressiveness of the tumor and the prognosis in patients with esophageal squamous cell carcinoma. During the preoperative diagnostic procedures, the sensitivity, specificity, and accuracy of lymph node staging is higher with FDG-PET than with computed tomography imaging.
You have free access to this content Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage (pages 929–933)
Kentaro Kato, Yasuhiro Hida, Masaki Miyamoto, Hideaki Hashida, Toshiya Shinohara, Tomoo Itoh, Shunichi Okushiba, Satoshi Kondo and Hiroyuki Katoh
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10329
Over-expression of caveolin-1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and prognosis after surgery.
You have free access to this content Coexpression of ephrin-Bs and their receptors in colon carcinoma (pages 934–939)
Wenbiao Liu, Syed A. Ahmad, Young D. Jung, Niels Reinmuth, Fan Fan B.S., Corazon D. Bucana and Lee M. Ellis
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10122
Ephrins are cell membrane-associated ligands that are important in embryologic development and that bind to the family of tyrosine kinase receptors, Ephs. Using Northern blot analysis and immunohistochemistry, the results of the current study demonstrate that ephrin-B ligands and EphB receptors are expressed at higher levels in colon carcinoma compared with normal mucosa, suggesting a role in for this ligand-receptor system in the progression of colon carcinoma.
You have free access to this content Serum cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma (pages 940–949)
Yoshihiro Nabeya, Hideaki Shimada, Shinichi Okazumi, Hisahiro Matsubara, Yoshio Gunji, Takao Suzuki and Takenori Ochiai
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10267
This document describes the clinical significance of determining serum levels of cross-linked carboxyterminal telopeptide of Type I collagen as a novel prognostic tumor marker of the progression of esophageal squamous cell carcinoma.
You have free access to this content Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs : A review (pages 950–963)
Nicholas J. Shaheen, Walter L. Straus and Robert S. Sandler
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10333
The chronic use of nonsteroidal antiinflammatory drugs has been associated with a decreased risk of multiple different gastrointestinal (GI) malignancies. In the current study, the authors review possible mechanisms of chemoprevention, the data assessing the strength and magnitude of any risk reduction for major GI malignancies, and future directions in chemoprevention research.
Genitourinary Disease You have free access to this content Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? : A multicenter retrospective study in Japan (pages 964–972)
Shigeru Kosuda, Ichiro Yoshimura, Taku Aizawa, Kiyoshi Koizumi, Koichiro Akakura, Junpei Kuyama, Kiyoshi Ichihara, Junji Yonese, Mitsuru Koizumi, Jun Nakashima and Hirofumi Fujii
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10340
To determine whether the need for bone scans can be eliminated for Japanese patients with newly diagnosed prostate carcinoma with prostate specific antigen (PSA) levels ≤ 10 ng/mL, the authors conducted a retrospective assessment and used two competing strategies: PSA alone and PSA plus baseline bone scans. The two strategies yielded identical 10-year disease free survival rates, whereas the PSA-alone strategy was minimally cost effective.
You have free access to this content Low expression of p27 Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma (pages 973–979)
Toshiro Migita, Yoshinao Oda, Seiji Naito and Masazumi Tsuneyoshi
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10338
In an immunohistochemical assessment of the expression of p27
Kip1 (p27) and related cyclins in patients with renal cell carcinoma (RCC), these proteins and clinicopathologic factors were analyzed to determine the prognostic significance of cell cycle parameters. The results suggest that low p27 expression may be a significant and independent, unfavorable prognostic factor in patients with RCC. You have free access to this content HER-2 profiling and targeting in prostate carcinoma : A Phase II trial of trastuzumab alone and with paclitaxel (pages 980–986)
Michael J. Morris, Victor E. Reuter, W. Kevin Kelly, Susan F. Slovin, Kate Kenneson, David Verbel, Iman Osman and Howard I. Scher
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10339
Trastuzumab is ineffective for patients with androgen independent prostate carcinoma who have tumors that do not overexpress HER-2. HER-2 expression varies by clinical state. Accurate profiling in patients with metastatic disease requires sampling metastatic tissue, which stymies further efforts to identify patients with HER-2 positive tumors for clinical trials.
You have free access to this content Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy (pages 987–996)
Ganesh V. Raj, Alan W. Partin and Thomas J. Polascik
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10337
111Indium-capromab pendetide immunoscintigraphy may detect early recurrent prostate carcinoma (serum prostate specific antigen ≤ 4.0 ng/mL) after patients undergo radical prostatectomy and may be better for selecting men with local disease only for salvage radiation therapy. Gynecologic Oncology You have free access to this content Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma (pages 997–1005)
Atia A. Hamid, Masaki Mandai, Ikuo Konishi, Kanako Nanbu, Yuko Tsuruta, Takashi Kusakari, Masatoshi Kariya, Masato Kita and Shingo Fujii
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10341
This study shows that hMSH2 is likely to be associated with maintaining cyclical changes in endometrial glands. In most patients with endometrial carcinoma and hyperplasia, hMSH2 protein expression was enhanced, which may be compatible with an increased need for DNA mismatch repair in a setting of increased cellular proliferation.
Head and Neck Disease You have free access to this content Serum folate and homocysteine levels in head and neck squamous cell carcinoma (pages 1006–1011)
Giovanni Almadori, Francesco Bussu, Jacopo Galli, Gabriella Cadoni, Bruno Zappacosta, Silvia Persichilli, Angelo Minucci and Bruno Giardina
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10343
Serum folate and homocysteine status is significantly impaired in head and neck squamous cell carcinoma patients. This could be a consequence of tumor progression or it could suggest a role for hypofolatemia as a risk factor for head and neck carcinoma.
You have free access to this content Quality of life of nasopharyngeal carcinoma patients (pages 1012–1017)
Yoav P. Talmi, Zeev Horowitz, Lev Bedrin, Michael Wolf, Gavriel Chaushu, Jona Kronenberg and M. Raphael Pfeffer
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10342
Nasopharyngeal carcinoma patients comprise a unique subgroup in whom, to the authors' knowledge, the quality of life (QOL) has not been studied directly. Dry mouth, chewing, and ear problems were of major concern in the majority of patients and were found to affect QOL indices.
Hepatobiliary Tract You have free access to this content Ossifying malignant mixed epithelial and stromal tumor of the liver : A case report of a previously undescribed tumor (pages 1018–1022)
Glenroy Heywood, Lawrence J. Burgart and David M. Nagorney
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10345
The authors describe the clinicopathologic features of a morphologically distinctive malignant tumor of the liver characterized by neoplastic spindle cell proliferation with adenocarcinoma and osteoid differentiation which showed an indolent course. Histologically, the authors suggest the name “ossifying malignant mixed epithelial and stromal tumor of the liver”.
Lung You have free access to this content Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma (pages 1023–1031)
Serap Hastürk, Bonnie Kemp, Shyla K. Kalapurakal, Jonathan M. Kurie, Waun K. Hong and Jin S. Lee
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10262
The authors conducted the current study to examine the potential utility of cyclooxygenase (Cox) expression as an intermediate biomarker in lung carcinoma chemoprevention trials. They examined the expression of Cox 1 and Cox 2 enzymes in normal and premalignant lesions such as bronchial squamous metaplasia and nonsmall cell lung carcinoma cells. Their results indicate that Cox 1 and Cox 2 expression may not be a useful intermediate biomarker in these bronchial chemoprevention trials.
You have free access to this content Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients (pages 1032–1036)
Issam Raad, Hend Hanna, David Sumoza and Maher Albitar
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10349
The premortem diagnosis of invasive pulmonary aspergillosis (IPA) is difficult to make and often missed. The current study was conducted in cancer patients with pneumonitis to determine prospectively the diagnostic usefulness of polymerase chain reaction on whole blood to establish the diagnosis of IPA.
Neuro-Oncology You have free access to this content Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors (pages 1037–1048)
Fernanda Martini, Lorena Lazzarin, Laura Iaccheri, Beatrice Vignocchi, Gaetano Finocchiaro, Ivana Magnani, Massimo Serra, Katia Scotlandi, Giuseppe Barbanti-Brodano and Mauro Tognon
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10272
In this study, distinct SV40 genomic regions were detected at high frequency in human brain and bone tumors of different histotypes, whereas normal bone tissues were SV40 negative. SV40 sequences were also detected in buffy coats from blood donors but at lower prevalence. Brain and bone tumor specimens found SV40 positive expressed the specific large T-antigen mRNA. SV40 may act as a cocarcinogenic agent in the onset/progression of specific human tumors, whereas leukocytes are vectors of SV40 in host tissues.
Melanoma and Skin You have free access to this content Prognostic factors in patients with thick cutaneous melanoma (> 4 mm) (pages 1049–1056)
Elizabeth Zettersten, Richard W. Sagebiel, James R. Miller III, Sreedhar Tallapureddy, Stanley P. L. Leong and Mohammed Kashani-Sabet
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10326
This study of 329 patients with thick cutaneous melanoma examined the influence of multiple histopathologic and clinical risk factors on the overall survival of this patient cohort. Several factors, in addition to tumor thickness and lymph node status, were found to influence the survival of these patients significantly.
Soft Tissue You have free access to this content Clinicopathologic correlates of solitary fibrous tumors (pages 1057–1068)
Jason S. Gold, Cristina R. Antonescu, Cristina Hajdu, Cristina R. Ferrone, Mustafa Hussain, Jonathan J. Lewis, Murray F. Brennan and Daniel G. Coit
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10328
A series of 79 solitary fibrous tumors arising at a wide range of anatomic sites is described. Factors predicting local recurrence-free and metastasis-free survival are analyzed.
You have free access to this content Osteosarcoma of the spine : Experience of the Cooperative Osteosarcoma Study Group (pages 1069–1077)
Toshifumi Ozaki, Silke Flege, Ulf Liljenqvist, Axel Hillmann, Günter Delling, Mechthild Salzer-Kuntschik, Heribert Jürgens, Rainer Kotz, Winfried Winkelmann and Stefan S. Bielack
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10258
Patients with osteosarcoma of the spine who have metastasis, large tumors, and sacral tumors have a poor prognosis. These patients seem to be treated effectively with a combination of chemotherapy, at least marginal excision (for patients with surgically accessible tumors), and postoperative radiotherapy.
Discipline Pathology You have free access to this content Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia (pages 1078–1082)
Tamara Kalir, Beverly Y. Wang, Michael Goldfischer, Richard S. Haber, Ilan Reder, Rita Demopoulos, Carmel J. Cohen and David E. Burstein
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10280
GLUT1 is a consistent marker of ovarian epithelial malignancy. Anti-GLUT1 antibody may be useful in distinguishing invasive from noninvasive borderline implants.
You have free access to this content Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma (pages 1083–1093)
Hiroshi Kojima, Noriharu Shijubo and Shosaku Abe
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10352
Thymidine phosphorylase (TP) induction in intratumoral stroma, but not in tumor cells, and tumor cell-vascular endothelial growth factor (VEGF) induction cooperatively may promote angiogenesis in adenocarcinoma of the lung. Stromal cell-TP and tumor cell-VEGF induction may be important prognostic factors in lung adenocarcinoma.
Pediatric Oncology You have free access to this content Nonperioperative strokes in children with central nervous system tumors (pages 1094–1101)
Daniel C. Bowers, Arlynn F. Mulne, Joan S. Reisch, Roy D. Elterman, Louis Munoz, Timothy Booth, Kenneth Shapiro and Deborah L. Doxey
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10353
The incidence of nonperioperative strokes among children with central nervous system tumors was 4.03 strokes/1000 years of patient follow-up. Strokes were associated with treatment with radiation therapy and a diagnosis of an optic pathway glioma.
You have free access to this content Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia (pages 1102–1110)
Nyla A. Heerema, Harland N. Sather, Martha G. Sensel, Mei K. L. La, Raymond J. Hutchinson, James B. Nachman, Gregory H. Reaman, Beverly J. Lange, Peter G. Steinherz, Bruce C. Bostrom, Paul S. Gaynon and Fatih M. Uckun
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10325
Aberrations of chromosome bands 15q13-15 occur in about 1% of children with acute lymphoblastic leukemia (ALL), implicating genes in this region in the leukemogenesis of some childhood ALL. With current intensive therapy, such aberrations do not appear to confer increased risk of treatment failure.
You have free access to this content Surgical view of the treatment of patients with hepatoblastoma : Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group (SIOPEL-1) (pages 1111–1120)
J. Marco Schnater, Daniël C. Aronson, Jack Plaschkes, Giorgio Perilongo, Julia Brown, Jean-Bernard Otte, Laurences Brugieres, Piotr Czauderna, Gordon MacKinlay and Anton Vos
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10282
This article describes surgical aspects in the first prospective trial designed by the Liver Tumor Study Group of the International Society of Pediatric Oncology (SIOPEL-1). The intention in SIOPEL-1 was to treat all patients with preoperative chemotherapy. The primary objective of this article was to assess whether the assumed surgical advantages of primary chemotherapy stand up to more detailed scrutiny.
Radiation Oncology You have free access to this content Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy (pages 1121–1130)
Hanifa Bouzourene, Fred T. Bosman, Walter Seelentag, Maurice Matter and Philippe Coucke
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10327
Tumor regression as well as residual tumor cell density were found to be predictive factors of survival in patients with rectal carcinoma after preoperative radiotherapy. The use of a standardized approach for pathologic evaluation must be implemented to allow comparison between the results of various treatment approaches.
You have free access to this content Combined chemotherapy and radiation therapy for head and neck malignancies : Quality of life issues (pages 1131–1141)
Nam P. Nguyen, Sabah Sallah, Ulf Karlsson and John E. Antoine
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10257
The standard of care for locally advanced head and neck carcinoma traditionally has been surgery followed by radiation therapy. However, the survival rate with this approach is poor. Concurrent chemotherapy and radiation was introduced to improve outcome, with excellent local control and survival results reported in both Phase II and Phase III studies. This review article summarizes the findings from published series of surgery, postoperative radiation, radiation therapy alone, and chemoradiation with regard to quality of life issues for patients with locally advanced head and neck carcinoma.
Integrated Medicine You have free access to this content Outpatient cancer drug costs : Changes, drivers, and the future (pages 1142–1150)
R. J. Halbert, Carol Zaher, Sally Wade, Jennifer Malin, Grant D. Lawless and Robert W. Dubois
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10347
The authors analyzed outpatient drug claims for health maintenance organization patients with a solid tumor diagnosis in the years 1995 and 1998 to quantify trends in drug expenditures. Total outpatient drug charges increased 16% annually, with antineoplastic therapy as the single most important driver of cost increases. The primary explanation for the increases appeared to be a shift in treatment patterns away from older, less expensive drugs toward newer, more expensive agents.
You have free access to this content Acupuncture for xerostomia : Clinical update (pages 1151–1156)
Peter A. S. Johnstone, Richard C. Niemtzow and Robert H. Riffenburgh
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10348
Radiation-induced dry mouth is alleviated by acupuncture for many patients.
Epidemiology You have free access to this content Familial and second gastric carcinomas : A nationwide epidemiologic study from Sweden (pages 1157–1165)
Kari Hemminki and Yongwen Jiang
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10322
Data from the Swedish Family-Cancer Database show familial risks in gastric carcinoma that can best be explained by environmental factors. Host immunity may modulate the risk of gastric carcinoma.
You have free access to this content The specific role of isoflavones on estrogen metabolism in premenopausal women (pages 1166–1174)
Nagi B. Kumar, Alan Cantor, Kathy Allen, Diane Riccardi and Charles E. Cox
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10320
The authors evaluated of the effectiveness of supplementing a group of premenopausal women who were free of breast carcinoma with a dietary supplement of isoflavones (40 mg per day) to determine whether it produced a change in female steroid hormone levels and menstrual cycle length, factors that are implicated in the reduction of breast proliferation and, thus, in the reduction of the risk for breast carcinoma.
You have free access to this content Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas (pages 1175–1182)
Scarlett S. Lin, Christina A. Clarke, Angela W. Prehn, Sally L. Glaser, Dee W. West and Cynthia D. O'Malley
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10319
This study examined overall and stage specific survival using cause-of-death information for three Asian subgroups (Chinese, Japanese, and Filipinos) in comparison with non-Hispanic whites. Results show differences in distribution of stage at diagnosis among the Asian subgroups and differences in 5-year survival that persist regardless of stage.
You have free access to this content Cancer trends among Hispanic men in South Florida, 1981–1998 (pages 1183–1190)
James D. Wilkinson, Brad Wohler-Torres, Edward Trapido, Lora E. Fleming, Jill MacKinnon, Lydia Voti and Steven Peace
Version of Record online: 20 FEB 2002 | DOI: 10.1002/cncr.10321
The authors report on 18 years of incidence and mortality data from Florida's population-based cancer registry for Hispanic men in Miami-Dade County, Florida. Hispanic men had an overall decreased incidence of cancer compared with non-Hispanic white men, although cancer mortality rates for these two groups appear to be converging in recent years.